Written Content and Email
Classic written marketing content and email marketing may seem like an old way of doing things and on the brink of extinction, but according to Krishen Iyer, a Carlsbad based entrepreneur and Marketing CEO, it still has huge potential. Data limitation and slow internet speeds drive many people to turn their searches towards written content as it uploads faster and uses fewer internet data compared to visual content. Visual content may have a more obvious or immediate impact on viewers, but one cannot ignore the fact that there are still many people who prefer to seek out information on the internet which uploads faster. Krishen Iyer also suggests that if you don’t have a Blog tab on your website, you should consider creating one since blog posts enhance your visibility on Google search engine which results in a higher amount of organic traffic to your site. Another marketing method that is often considered to be irrelevant by many people is email marketing. However, according to Krishen Iyer, you can take advantage of this marketing technique and make it work over the long term if you adjust your strategies to current trends. According to Iyer, the key to email marketing success is to make it as personal as possible. See more highlights about marketing by Iyer https://ideamensch.com/krishen-iyer/
Although many marketing experts have moved away from Facebook marketing, claiming it is losing its relevance. Krishen Iyer lists several reasons why it can still be an excellent marketing strategy. Marketing with Facebook is much less expensive than any other social media platform. According to Krishen Iyer, you can target the age which best fits your target audience and bypasses all other ages which will save a lot of time and money as you can more accurately reach the audience that fits your particular marketing strategy. You can also customize your strategies by watching the results you are getting and can pause or stop the ad service with just one click. Krishen Iyer pointed out these strategies, highlighting the new potential for classic marketing strategies.
Click here to connect with Iyer.
Nitin Khanna seeks to bolster the small business atmosphere of Portland, Oregon. The former co-founder of Saber Corp, which sold for $420 million in 2007 to Electronic Data Systems, is now the Chief Executive Officer (CEO) of MergerTech.
MergerTech is an investment firm that specializes in mergers and acquisitions of technology companies with a valuation of between $10 million and $200 million. To put it simply, MergerTech matches sellers with buyers across a global network of technology companies.
Nitin Khanna began the company with his brother and Chief Operations Officer (COO), Karan Khanna, after spinning the company off from Martin Wolf Securities, which was previously simply a subsidiary. Recognizing the unique niche to fill, Nitin Khanna has been extremely successful in its short existence, matching seven sellers with buyers in its first seven months of independent operation. This is further elaborated in this link.
According to Nitin Khanna, MergerTech’s success begins with its people. MergerTech thrives from hiring highly qualified and competent persons to manage and perform the different aspects of MergerTech’s complex business. Because MergerTech signs the majority of potential clients to contracts, for their merger or acquisition, Nitin Khanna likes to know the right people are handling the job beyond his initial duties.
Nitin Khanna is not only a successful businessman, but a supporter of the Portland Oregon business community. MergerTech is a testament to that. The goal of MergerTech is to bolster the business community by attracting, first, angel investors and then, second, venture capitalists. If MergerTech can bring more investment to the community through mergers and acquisitions, then angel investors and venture capitalists are likely to follow. You can find out more about the new ventures of this successful business man here https://medium.com/@NitinKhannaCeo/nitin-khanna-riding-the-cannabis-wave-with-cura-cannabis-solutions-9fcf612ee529
According to Nitin Khanna, Angel investors must come first in any investment. A regular supply of wealthy individuals seeking to invest in Portland startups precedes larger venture capitalist firms, which could bring greater prosperity to the community.
Follow Nitin on Twitter.
Marc Beer is the business genius behind the scenes of the inventive biotech company Renovia. The startup CEO is also the former founder of Aegerion Pharmaceuticals. Renovia is a biotech startup centered around examining and delivering accommodating and inventive devices for women with pelvic floor medical problems. Marc coordinated the startup’s Series B round of monetary support, which rounds off to around $40 million. This empowers the startup to progress and release various new things geared toward pelvic floor issues.
Boston, Massachusetts, is the headquarters of Renovia. It was founding to put a definitive dent in the issues that can be brought on by pelvic floor disorders. It is really focusing on making urinary incontinence in women a thing of the past. The typical individual has no clue the number of women living with this issue far and wide. It is estimated that as many as 250 million females have pelvic floor issues. The FDA approved the startups flagship drug Leva in April of this year.
The Longwood Fund has contributed more funds than any other investor to date to Renovia. The firm was one of the earliest investors and continues to support monetarily. Renovia envisions using the funding as way to improve upon the amount of devices it can offers to customers.
Marc Beer has given a plenitude of acclaim to the individuals who added to Renovia pace of reaching it goals. Marc will keep on helping those harrowed by pelvic floor issues by means of the biotech startup.
Marc really began making a name for himself in the industry with the founding of Aegerion. He remained with the company for 5 years before leaving to found Renovia. Though he had to start completely over with the startup he took on the challenge in stride.
Marc Beer is a standout individual among the most experienced people in the biotech industry. he is also a pretty well respected pharmaceutical professional as well. Marc demonstrated to himself that he could be a fruitful business visionary when he established Viacell almost 20 years ago. He supervised the organization opening up to the world in 2005, preceding pitching it to PerkinElmer. Learn more: https://www.businesswire.com/news/home/20180821005199/en/Renovia-Completes-42.3-Million-Series-Financing